Kathryn Fideler, MD
Adult Reconstructive Orthopaedic Surgery · Miami Beach, FLNPI 1568997534
Payments from drug & device makers
What this record shows
This record is dominated by education: $19,200 of the $27,364 with a category attached, or 70.2%. Smith+Nephew accounts for 66.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $11,430 and has fallen 93.8% since, to $711 in 2025.
Across 65 payments — averaging $420.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$18K
- Depuy Synthes Products, Inc.$4K
- Medical Device Business Services, Inc.$2K
- CDC Medical LLC$1K
- Stryker$774
- Johnson & Johnson$519
- plus $777 from 9 others
What the payments were for
- Consulting fees$2,78910%
- Travel & lodging$2,2848%
- Food & beverage$3,09111%
- Education$19,20070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $18,234 |
| Depuy Synthes Products, Inc. | 6 | $3,501 |
| Medical Device Business Services, Inc. | 30 | $2,359 |
| CDC Medical LLC | 1 | $1,200 |
| Stryker | 6 | $774 |
| Johnson & Johnson | 6 | $519 |
| Medartis Inc. | 2 | $225 |
| Linkbio Corp | 1 | $146 |
| Integra Lifesciences Corporation | 1 | $117 |
| Orthalign Inc | 2 | $103 |
| Merz North America, Inc. | 1 | $89 |
| Solventum Corporation | 1 | $36 |
| ERMI LLC | 1 | $24 |
| Fidia Pharma USA Inc. | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIS$1,293
- MAKO$600
- ATTUNE$370
- INTEGRA$351
- Velys$309
- APTUS$225
- REAL INTELLIGENCE$127
- INTEGRA DERMAL REGENERATION TEMPLATE$117
- PRIMATRIX$117
- Kincise$107
How this compares
$27,364 in reported general payments places this provider in the 65th percentile of 96 adult reconstructive orthopaedic surgery providers in Florida.
See all adult reconstructive orthopaedic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 108 | $2,087 |
| Meloxicam | 171 | $436 |
| Methylprednisolone | 25 | $229 |
| Tramadol Hcl | 43 | $173 |
| Oxycodone Hcl | 28 | $140 |
| Ondansetron Hcl | 17 | $37 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Miami Beach
- Carlos LaverniaMiami$5.4M
- Juan SuarezMiami$3.9M
- John RedmondJacksonville$987K
- Gavan DuffyJacksonville$543K
- Timothy van de LeurSummerfield$511K
- Edward StolarskiSarasota$445K
- Andrew NoblePalm Beach Gardens$308K
- Raul GostheMiami$252K
- Chancellor GrayGainesville$228K
- David BacksteinNaples$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.